20-hydroxy-5,8,11,14-eicosatetraenoic acid and organophosphonates

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with organophosphonates in 2 studies

Compound Research Comparison

Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Studies (organophosphonates)	Trials (organophosphonates)	Recent Studies (post-2010) (organophosphonates)
640	13	233	9,968	880	3,596

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Malik, KU; Muthalif, MM; Nishimoto, AT; Parmentier, JH	1
Akhtar, S; Benter, IF; Canatan, H; Yousif, MH	1

Other Studies

2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and organophosphonates

Article	Year
20-Hydroxyeicosatetraenoic acid mediates angiotensin ii-induced phospholipase d activation in vascular smooth muscle cells. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Angiotensin II; Animals; Arachidonic Acids; Cells, Cultured; Ceramides; Cyclohexanones; Enzyme Inhibitors; Glycerophospholipids; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Organophosphonates; Phospholipase D; Propranolol; Rabbits	2001
Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery. Pharmacological research, 2005, Volume: 52, Issue:3 Topics: Amidines; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Experimental; Hydroxyeicosatetraenoic Acids; Monomeric GTP-Binding Proteins; Organophosphonates; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Triazoles; Vascular Diseases; Vasoconstriction; Vasodilation	2005

Article

Year

20-Hydroxyeicosatetraenoic acid mediates angiotensin ii-induced phospholipase d activation in vascular smooth muscle cells.

Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2

Topics: Angiotensin II; Animals; Arachidonic Acids; Cells, Cultured; Ceramides; Cyclohexanones; Enzyme Inhibitors; Glycerophospholipids; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Organophosphonates; Phospholipase D; Propranolol; Rabbits

2001

Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery.

Pharmacological research, 2005, Volume: 52, Issue:3

Topics: Amidines; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Experimental; Hydroxyeicosatetraenoic Acids; Monomeric GTP-Binding Proteins; Organophosphonates; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Triazoles; Vascular Diseases; Vasoconstriction; Vasodilation

2005